| 11:18 – 'No football, no kits': Roy Keane responds to Wayne Rooney joking about Saipan film | 11:17 – Tottenham’s opening bid for Jan Paul van Hecke rejected by Brighton | 11:03 – Two men charged over Southampton disorder after Henry Nowak murder | 10:58 – Deposit return machines pose no biological risk to public health, study finds | 10:50 – Progress Ireland argues Europe must 'relearn how to build'

IDa Business Park

Laboratory Technicians Handle Capped Vials As Part Of Filling And Packaging Tests For The Large-Scale Production And Supply Of The University Of Oxfords Covid-19 Vaccine Candidate, Azd1222, Conducted On A High-Performance Aseptic Vial Filling Line On September 11, 2020 At The Italian Biologics Manufacturing Facility Of Multinational Corporation Catalent In Anagni, Southeast Of Rome, During The Covid-19 Infection, Caused By The Novel Coronavirus. - Catalent Biologics Manufacturing Facility In Anagni, Italy Will Serve As The Launch Facility For The Large-Scale Production And Supply Of The University Of Oxfords Covid-19 Vaccine Candidate, Azd1222, Providing Large-Scale Vial Filling And Packaging To British-Swedish Multinational Pharmaceutical And Biopharmaceutical Company Astrazeneca. (Photo By Vincenzo Pinto / Afp) (Photo By Vincenzo Pinto/Afp Via Getty Images)

Ireland

Horizon Therapeutics announce 350 new jobs for Waterford

Advertisement